drugset / Trial / NCT03139422

Treatment of Copper Intra Uterine Device Associated Heavy Menstrual Blood Loss

NCT03139422

Phase 3 Unknown 140 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

Intrauterine contraceptive device is the most commonly reversible method used among women of reproductive age worldwide. Almost one in five married contraceptive users is currently using Intrauterine contraceptive device. The Egyptian demographic and health survey results indicate that 30% of currently married women interviewed in the Egyptian demographic and health survey were using Intrauterine contraceptive device. Main reasons for discontinuation of Intrauterine contraceptive device as cited by women were excessive bleeding per vagina 39.68%, abdominal pain 38.62%, low backache35.97%.

Timeline

Start
2017-07-01
Primary completion
2018-10
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium Dobesilate Unknown 500 mg Oral
Comparator Tranexamic Acid Small molecule 500 mg Oral

Indications